Applications are now closed.
You are encouraged to express your interest if you would like this course to be offered again in the future.
Who should apply?
- The course is most suitable for those directly supporting national immunization planning.
- We encourage national, sub-national, and district EPI management staff, WHO/UNICEF country and regional staff, in-country partner organization staff and consultants to apply.
- Women are especially encouraged to apply.
As an immunization professional working at the national or sub-national level, you are the key to realizing the IA2030 vision and strategy in your local context.
Course schedule overview
Active participation is required for the entire duration on the course.
3-7 May 2021: Onboarding week – Join course platforms & participate in IA2030 briefing
10-14 May 2021: Orientation week – Complete short daily tasks to prepare your learning
17-21 May 2021: Week 1 – Identify one strategic priority in IA2030 and integrate core principles and key areas of focus most relevant to your country context
24-28 May 2021: Week 2 – Peer review the selected strategic priority and key areas of focus of three other course participants
31 May-4 June 2021: Week 3 – Submit your IA2030 action plan to achieve better immunization outcomes
7-11 June 2021: Week 4 – Peer review action plans developed by three other course participants
14-18 June 2021: Week 5 – Peer review action plans developed by three other course participants
21-25 June 2021: Week 6 – Revise and finalize your own IA2030 action plan
Scholars who successfully complete the course are expected to be able to:
- Describe IA2030’s seven strategic priorities and four core principles
- Identify strategic priorities and focus areas that are likely to transform your national immunization programme and the work of global partners;
- Define the problem and prioritize recommendations to select a suggested action that could have the greatest impact on the current state in your country;
- Identify best practices in the suggested action through literature review and dialogue with your peers;
- Explore innovative ways to implement strategic priorities in your country context;
- Compare and share best practices with practitioners from all over the world, drawing on global expertise from WHO.
Resources and prerequisites
- Immunization Agenda 2030 (IA2030): Participants should download and familiarize themselves with Immunization Agenda 2030.
- Access to EPI data: For the country(ies) you support, you will be expected to have access to routine administrative coverage data, assessment reports for programme reviews, specialized assessments such as PIEs (Post-Introduction Evaluation), EVMs (Effective Vaccine Management) assessments and HW KAPs (Health Worker Knowledge Attitudes and Practices).
What you will do
- Complete successive writing assignments to develop a practical plan suitable for implementation, focused on a selected priority area, integrating core principles and key areas of focus into your context.
- Peer review the drafts of other participants to learn from and provide constructive inputs.
- Revise your draft activities, drawing on what you learned from peer review, resources and ongoing dialogue in the course.
- Contribute at least once a week to community dialogue and live online sessions.
What you will gain
- Develop a project that is intended to be suitable for implementation in your own context, contribute to the development of your national IA2030 plan, and shape WHO technical experts’ understanding of Immunization Agenda as a living document.
- Connect with a global community committed to improving immunization and working toward country impact.
- Learn from your peers through both formal and informal dialogue as well as giving and receiving feedback.
- Compare and share best practices with peers and global experts from WHO.
- Earn a certificate of participation from WHO to demonstrate your learning and practice.
- Develop your digital skills to collaborate and learn remotely.
Participants should expect to:
- dedicate at least 6-8 hours per week to course work.
- participate remotely in the weekly, 60-minute group discussion that will take place online once a week. (Recordings of these sessions will be made available for those who are unable to attend for valid reasons.)
Each set of course activities must be completed within a given week. Participants may schedule their work at any time during the week, except for the weekly group session which is scheduled at a fixed day and time each week. (Those unable to attend for a legitimate reason will be asked to view the session recording to complete a catch-up task.)
In addition to these required activities, live events on specific topics of IA2030 will be organized.
Applicants are responsible for ensuring that they are able to meet the following requirements.
- Information technology: You will need to access web-based digital platforms, watch or download videos, download and upload documents, and use Zoom for live sessions. Participants need to have access to a reliable Internet connection and a standards-based browser less than two years old (Firefox, Safari, or Chrome). Internet Explorer and Microsoft Edge users will be asked to use a standards-based browser for the course. Mobile-only users will need to use Mobile Chrome in desktop mode when working on their course projects.
- Internet access: Specific guidance will be provided to those who have bandwidth limitations, intermittent access, or may suffer from disruption of their connection to the Internet.
- Language: The course is being offered twice, once in French and once in English. Participants are encouraged to schedule extra time if they are not fully proficient writing in the course language.
What is the challenge?
Immunization is one of the best health investments money can buy.
- Yet despite tremendous progress, far too many people around the world – including nearly 20 million infants each year – have insufficient access to vaccines.
- In some countries, progress has stalled or even reversed, and there is a real risk that complacency will undermine past achievements.
How is the global community responding?
To address these challenges over the next decade, a new global vision and strategy titled ‘Immunization Agenda 2030: A Global Strategy to Leave No One Behind (IA2030)’ has been endorsed by the World Health Assembly.
IA2030 requires broad ownership by all immunization and non-immunization stakeholders, including both health system strengthening and disease-specific initiatives. While WHO was asked to lead the development of IA2030, all stakeholders co-created, co-developed and now co-own it.
What are the goals of this WHO Scholar Level 1 certification course?
This is the first WHO Scholar course that – in line with Immunization Agenda 2030 – explicitly aims to ‘close the loop’ by more actively engaging global immunization leaders in listening and learning from participants. This WHO Scholar Level 1 certification course aims to:
- foster awareness, application, feedback and revision of the IA2030 framework, related activities and documents at all levels of the immunization programme, and
- help you integrate IA2030 strategies and priorities into your immunization context to achieve national, regional and global goals.
How you will shape WHO’s work through your participation in this course
- Immunization Agenda 2030 is intended to be tailored to your country’s context, using cooperative design from the bottom up, and adaptable to changing needs and new, emergent challenges.
- WHO and global partners are committed to learning from you through this course. In fact, when you complete the application, you will find that we ask you to document a specific challenge that you face in your work.
- Your challenges will be shared with WHO technical experts to inform their work, as well as to help adapt the course to fit your needs.
Upon successful completion of the course and following validation of your final project and assignments by the course team and subject matter experts at WHO, you will receive a certificate of participation from the World Health Organization. Each certificate is valid for a duration of three years. Certificate holders agree to show upon request a portfolio of their work that includes the project(s) produced in Scholar.
Confidentiality and data protection
This initiative uses the Privacy by Design approach. This means that we think of privacy implication before offering a course, we don’t ask for information we don't need, and we protect the information you share. We take pride in treating our learners’ privacy the way we would like to be treated, as individuals. We will treat your information with respect.
The Geneva Learning Foundation’s Scholar communities are devoted to learning and the creation of knowledge. We view integrity as the basis for meaningful collaboration. We thus hold honesty – in the representation of our work and in our interactions – as the foundation of our community.
Members of each Scholar community commit themselves to producing course work of integrity – that is, work that adheres to the scholarly and intellectual standards of accurate attribution of sources, appropriate collection and use of data, and transparent acknowledgement of the contribution of others to their ideas, discoveries, interpretations, and conclusions. Cheating on assignments or projects, plagiarizing or misrepresenting the ideas or language of someone else as one’s own, falsifying data, or any other instance of dishonesty violates the standards of our community, as well as the standards of the wider world of immunization.
Scholar course participants are required to adhere to a strict Honor Code. Violation of the Honor Code may result in removal from the course, loss of certification (including prior Scholar certificates), and notification of your employer.
Research and evaluation
The Geneva Learning Foundation and its partners may review projects developed by Scholars and may consider some of them for use in their communication, advocacy and training effort. You will be asked for consent in your application.
Learners may also be invited to participate in research and evaluation by the Geneva Learning Foundation and its partners. Participation in this research is completely voluntary, and you may stop taking part at any time. In cases where learners do not consent, no learner data will be collected. Participation or non-participation will have no effect on assessment of your performance in the course or your present or future relationship with the organizations involved.